PERSPECTA

News from every angle

Back to headlines

Amgen (AMGN) Price Target Cut by Piper Sandler Despite Optimism

Piper Sandler has lowered its price target for Amgen (AMGN) even while maintaining long-term growth optimism for the company.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.